123 related articles for article (PubMed ID: 10321757)
1. Genetic markers in ulcerative colitis. Why are the results different?
Peña AS; Crusius JB; Meuwissen SG
Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):405-7. PubMed ID: 10321757
[No Abstract] [Full Text] [Related]
2. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies.
Papo M; Quer JC; Gutierrez C; Broch M; Casellas F; Pastor RM; Olona M; Richart C
Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):413-20. PubMed ID: 10321759
[TBL] [Abstract][Full Text] [Related]
3. The immuno-inflammatory reaction in Crohn's disease and ulcerative colitis: characterisation, genetics and clinical application. Focus on TNF alpha.
Louis E
Acta Gastroenterol Belg; 2001; 64(1):1-5. PubMed ID: 11322060
[TBL] [Abstract][Full Text] [Related]
4. Stool interleukin 1beta and interleukin 1 receptor antagonist concentrations in children with active ulcerative colitis and during recovery.
Wedrychowicz A; Stopyrowa J; Fyderek K; Miezynski W
Eur J Pediatr; 2003 Jul; 162(7-8):541-542. PubMed ID: 12719967
[No Abstract] [Full Text] [Related]
5. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients.
Aisenberg J; Legnani PE; Nilubol N; Cobrin GM; Ellozy SH; Hegazi RA; Yager J; Bodian C; Gorfine SR; Bauer JJ; Plevy SE; Sachar DB
Am J Gastroenterol; 2004 Mar; 99(3):432-41. PubMed ID: 15056081
[TBL] [Abstract][Full Text] [Related]
6. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist.
Mansfield JC; Holden H; Tarlow JK; Di Giovine FS; McDowell TL; Wilson AG; Holdsworth CD; Duff GW
Gastroenterology; 1994 Mar; 106(3):637-42. PubMed ID: 8119534
[TBL] [Abstract][Full Text] [Related]
7. Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease.
Song Y; Wu KC; Zhang L; Hao ZM; Li HT; Zhang LX; Qiao TD; Li CN; Fan DM
Chin J Dig Dis; 2005; 6(4):170-4. PubMed ID: 16246225
[TBL] [Abstract][Full Text] [Related]
8. [Polymorphism of the IL1RN gene in Spanish patients with ulcerative colitis].
González Sarmiento R; Araoz P; Rodríguez R; Oliveira A; Feranández Blanco I; Sánchez Rodríguez A
Med Clin (Barc); 1999 Jun; 112(20):778-9. PubMed ID: 10422059
[TBL] [Abstract][Full Text] [Related]
9. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians.
Carter MJ; di Giovine FS; Jones S; Mee J; Camp NJ; Lobo AJ; Duff GW
Gut; 2001 Apr; 48(4):461-7. PubMed ID: 11247888
[TBL] [Abstract][Full Text] [Related]
10. Distribution of an NcoI polymorphism in the lymphotoxin alpha gene in Dutch patients with inflamatory bowel diseases.
Xia B; Bouma G; Grusius JB; Meuwissen SG; Pena AS
Chin Med J (Engl); 1995 Oct; 108(10):739-42. PubMed ID: 8565658
[TBL] [Abstract][Full Text] [Related]
11. Cytokine gene polymorphisms in inflammatory bowel disease.
Louis E; Satsangi J; Roussomoustakaki M; Parkes M; Fanning G; Welsh K; Jewell D
Gut; 1996 Nov; 39(5):705-10. PubMed ID: 9014770
[TBL] [Abstract][Full Text] [Related]
12. Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.
Muro M; López-Hernández R; Mrowiec A
World J Gastroenterol; 2014 Nov; 20(41):15037-48. PubMed ID: 25386052
[TBL] [Abstract][Full Text] [Related]
13. Association of IL-10 and TNFalpha genotypes with ANCA appearance in ulcerative colitis.
Castro-Santos P; Suarez A; Mozo L; Gutierrez C
Clin Immunol; 2007 Jan; 122(1):108-14. PubMed ID: 17070109
[TBL] [Abstract][Full Text] [Related]
14. Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications.
Facklis K; Plevy SE; Vasiliauskas EA; Kam L; Taylor K; Targan SR; Fleshner PR
Dis Colon Rectum; 1999 May; 42(5):601-5; discussion 605-6. PubMed ID: 10344681
[TBL] [Abstract][Full Text] [Related]
15. Genetic heterogeneity in ulcerative colitis.
Lashner BA
Am J Gastroenterol; 1994 Nov; 89(11):1927-8. PubMed ID: 7942713
[No Abstract] [Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature.
Lombardi G; Annese V; Piepoli A; Bovio P; Latiano A; Napolitano G; Perri F; Conoscitore P; Andriulli A
Dis Colon Rectum; 2000 Jul; 43(7):999-1007. PubMed ID: 10910250
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease.
Folwaczny C; Noehl N; Endres SP; Loeschke K; Fricke H
Scand J Gastroenterol; 1998 May; 33(5):523-8. PubMed ID: 9648993
[TBL] [Abstract][Full Text] [Related]
18. Genetic markers may predict disease behavior in patients with ulcerative colitis.
Roussomoustakaki M; Satsangi J; Welsh K; Louis E; Fanning G; Targan S; Landers C; Jewell DP
Gastroenterology; 1997 Jun; 112(6):1845-53. PubMed ID: 9178675
[TBL] [Abstract][Full Text] [Related]
19. [The TNF family genes polymorphisms (-308G/A TNF and +252A/G LTA) and alcoholic liver disease].
Shangareeva ZA; Viktorova TV; Sagidullin AF
Mol Biol (Mosk); 2004; 38(6):1014-6. PubMed ID: 15612587
[No Abstract] [Full Text] [Related]
20. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.
Koss K; Satsangi J; Fanning GC; Welsh KI; Jewell DP
Genes Immun; 2000 Feb; 1(3):185-90. PubMed ID: 11196710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
